Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

Clinical trial NCT02269917 · COMPLETED

Trial details

NCT number

NCT02269917

Sponsor

Janssen R&D Ireland

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2015-03-01

Primary completion

2017-02-01

Enrollment

1149

View on ClinicalTrials.gov